AAAAAA

   
Results: 1-11 |
Results: 11
Overexpression of alpha2C-adrenoceptors impairs water maze navigation
Authors: Bjorklund, M Sirvio, J Riekkinen, M Sallinen, J Scheinin, M Riekkinen, P
Citation: M. Bjorklund et al., Overexpression of alpha2C-adrenoceptors impairs water maze navigation, NEUROSCIENC, 95(2), 2000, pp. 481-487
Clonidine, but not guanfacine, impairs choice reaction time performance inyoung healthy volunteers
Authors: Jakala, P Riekkinen, M Sirvio, J Koivisto, E Riekkinen, P
Citation: P. Jakala et al., Clonidine, but not guanfacine, impairs choice reaction time performance inyoung healthy volunteers, NEUROPSYCH, 21(4), 1999, pp. 495-502
Guanfacine, but not clonidine, improves planning and working memory performance in humans
Authors: Jakala, P Riekkinen, M Sirvio, J Koivisto, E Kejonen, K Vanhanen, M Riekkinen, P
Citation: P. Jakala et al., Guanfacine, but not clonidine, improves planning and working memory performance in humans, NEUROPSYCH, 20(5), 1999, pp. 460-470
THA improves word priming and clonidine enhances fluency and working memory in Alzheimer's disease
Authors: Riekkinen, P Riekkinen, M
Citation: P. Riekkinen et M. Riekkinen, THA improves word priming and clonidine enhances fluency and working memory in Alzheimer's disease, NEUROPSYCH, 20(4), 1999, pp. 357-364
Guanfacine and clonidine, alpha2-agonists, improve paired associates learning, but not delayed matching to sample, in humans
Authors: Jakala, P Sirvio, J Riekkinen, M Koivisto, E Kejonen, K Vanhanen, M Riekkinen, P
Citation: P. Jakala et al., Guanfacine and clonidine, alpha2-agonists, improve paired associates learning, but not delayed matching to sample, in humans, NEUROPSYCH, 20(2), 1999, pp. 119-130
Clonidine impairs sustained attention and memory in Alzheimer's disease
Authors: Riekkinen, M Laakso, MP Jakala, P Riekkinen, P
Citation: M. Riekkinen et al., Clonidine impairs sustained attention and memory in Alzheimer's disease, NEUROSCIENC, 92(3), 1999, pp. 975-982
The alpha(2) agonist, clonidine, improves spatial working memory performance in Parkinson's disease
Authors: Riekkinen, M Jakala, P Kejonen, K Riekkinen, P
Citation: M. Riekkinen et al., The alpha(2) agonist, clonidine, improves spatial working memory performance in Parkinson's disease, NEUROSCIENC, 92(3), 1999, pp. 983-989
alpha(2)-Adrenergic agonist clonidine for improving spatial working memoryin Parkinson's disease
Authors: Riekkinen, M Riekkinen, P
Citation: M. Riekkinen et P. Riekkinen, alpha(2)-Adrenergic agonist clonidine for improving spatial working memoryin Parkinson's disease, J CL PSYCH, 19(5), 1999, pp. 444-449
Tetrahydroaminoacridine and D-cycloserine fail to alleviate the water mazespatial navigation defect induced by hippocampal inactivation
Authors: Riekkinen, P Ikonen, S Aura, J Riekkinen, M
Citation: P. Riekkinen et al., Tetrahydroaminoacridine and D-cycloserine fail to alleviate the water mazespatial navigation defect induced by hippocampal inactivation, EUR J PHARM, 366(1), 1999, pp. 13-18
Clonidine impairs sustained attention in Alzheimer's disease
Authors: Riekkinen, M Laakso, MP Jakala, P Riekkinen, P
Citation: M. Riekkinen et al., Clonidine impairs sustained attention in Alzheimer's disease, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 641-647
D-cycloserine, a partial NMDA receptor-associated glycine-B site agonist, enhances reversal learning, but a cholinesterase inhibitor and nicotine hasno effect
Authors: Riekkinen, P Ikonen, S Riekkinen, M
Citation: P. Riekkinen et al., D-cycloserine, a partial NMDA receptor-associated glycine-B site agonist, enhances reversal learning, but a cholinesterase inhibitor and nicotine hasno effect, NEUROREPORT, 9(16), 1998, pp. 3647-3651
Risultati: 1-11 |